Organon & Co. Executive Compensation Revealed
Ticker: OGN · Form: DEF 14A · Filed: Apr 25, 2025 · CIK: 1821825
| Field | Detail |
|---|---|
| Company | Organon & CO. (OGN) |
| Form Type | DEF 14A |
| Filed Date | Apr 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, sec-filing, governance
Related Tickers: OGN
TL;DR
Organon's 2024 exec pay details are out - equity awards, pensions, and more.
AI Summary
Organon & Co. filed a DEF 14A on April 25, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted, outstanding, and vested, as well as pension adjustments and other compensation elements for its executive officers.
Why It Matters
This filing provides transparency into how Organon & Co. compensates its top executives, which can influence investor decisions and corporate governance.
Risk Assessment
Risk Level: low — This is a routine DEF 14A filing disclosing executive compensation, which is standard practice and does not inherently indicate new risks.
Key Players & Entities
- Organon & Co. (company) — Filer of the DEF 14A
- 0000950170-25-058795 (filing_id) — Accession number for the filing
- 20250425 (date) — Filing date
- 20250610 (date) — Report period end date
- 1231 (date) — Fiscal year end
FAQ
What is the primary purpose of this DEF 14A filing for Organon & Co.?
The primary purpose is to disclose information regarding the company's executive compensation, director compensation, and other corporate governance matters, as required by the SEC.
When was this DEF 14A filing submitted to the SEC?
This DEF 14A filing was submitted to the SEC on April 25, 2025.
What fiscal year does the compensation information in this filing primarily cover?
The compensation information in this filing primarily covers the fiscal year ending December 31, 2024.
What is Organon & Co.'s Central Index Key (CIK)?
Organon & Co.'s Central Index Key (CIK) is 0001821825.
Where is Organon & Co. headquartered?
Organon & Co. is headquartered at 30 Hudson Street, FL 33, Jersey City, NJ 07302.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 25, 2025 regarding Organon & Co. (OGN).